ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boots, A.W.
Right arrow Articles by Bast, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Boots, A.W.
Right arrow Articles by Bast, A.
Eur Respir J 2003; 22:14s-27s
Copyright ©ERS Journals Ltd 2003

Oxidant metabolism in chronic obstructive pulmonary disease

A.W. Boots, G.R.M.M. Haenen and A. Bast

Dept of Pharmacology and Toxicology, Faculty of Medicine, University of Maastricht, Maastricht, The Netherlands

CORRESPONDENCE: A. Bast, Dept of Pharmacology and Toxicology, Faculty of Medicine, University of Maastricht, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. Fax: 31 43 3884149. E-mail: A.Bast@farmaco.unimaas.nl

Keywords: chronic obstructive pulmonary disease, metabolism, oxidative stress, systemic

Received: June 30, 2003
Accepted June 30, 2003

The development and progression of chronic obstructive pulmonary disease (COPD) have been associated with increased oxidative stress or reduced antioxidant resources. Several indicators of oxidative stress, such as hydrogen peroxide exhalation, lipid peroxidation products and degraded proteins, are indeed elevated in COPD patients. As a result, the antioxidant capacity decreases in COPD patients.

The fall in antioxidant capacity of blood from COPD patients should not only be regarded as a reflection of the occurrence of oxidative stress but also as evidence that oxidative stress spreads out to the circulation and can therefore generate a systemic effect.

COPD is linked to weight loss and in particular to loss in fat­free mass by skeletal muscle wasting. This systemic effect can be mediated by both oxidative stress and oxidative stress­mediated processes like apoptosis and inflammation. Furthermore, COPD is a predisposition for lung cancer through several mechanisms including oxidative stress and oxidative stress­mediated processes such as inflammation and disruption of genomic integrity.

Current therapeutic interventions against the far­reaching consequences of the systemic oxidative stress in chronic obstructive pulmonary disease are not yet optimised. A diet designed to reduce chronic metabolic stress might form an effective therapeutic strategy in chronic obstructive pulmonary disease.




This article has been cited by other articles:


Home page
Eur Respir JHome page
M. P. Smit-de Vries, M. van der Toorn, R. Bischoff, and H. F. Kauffman
Resistance of quiescent and proliferating airway epithelial cells to H2O2 challenge
Eur. Respir. J., April 1, 2007; 29(4): 633 - 642.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Wehlin, M. Lofdahl, J. Lundahl, and M. Skold
Reduced Intracellular Oxygen Radical Production in Whole Blood Leukocytes From COPD Patients and Asymptomatic Smokers
Chest, October 1, 2005; 128(4): 2051 - 2058.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.